Foundation Medicine Expects Sharp Rise in Q4, FY2015 Revenues | GenomeWeb

NEW YORK (GenomeWeb) – Foundation Medicine today reported a sharp increase in preliminary revenue for the fourth quarter and full year 2015.

The company projects approximately $26.1 million in fourth quarter revenues, up 39 percent from $18.7 million in Q4 2014, and $93.2 million in full-year revenues, up 53 percent from $61.1 million in 2014. Analysts had estimated Q4 earnings of about $25 million for the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.